Proteomics

Dataset Information

0

THE PHARMACOLOGICAL RESCUE OF CFTR BY LUMACAFTOR (VX-809) IN THE CYSTIC FIBROSIS BRONCHIAL EPITHELIUM IS ASSOCIATED WITH AN EXTENSIVE REORGANIZATION OF MITOCHONDRIA.


ABSTRACT: Cystic Fibrosis (CF) is a genetic disorder CF is caused by mutations of the gene encoding for the cystic fibrosis transmembrane conductance regulator protein (CFTR), a transmembrane anion channel expressed at the apical membrane of several organs, including the epithelial cells of the airway. CFTR mutations result in dysfunctional ion transport across the apical membrane at the surface of the epithelia, generating thickened and dehydrated secretions. In the lung, this leads to a decrease in the mucociliary clearance, favoring bacterial colonization and progressive obstruction of the duct. Although over 2000 CFTR variants have been identified so far, the most common mutation is a deletion of the phenylalanine in position 508 (F508del), which shows an allelic frequency of around 90% among CF patients. F508del-CFTR is incorrectly folded, causing its retention at the endoplasmic reticulum (ER) and subsequent proteasomal degradation. Among the several drugs available in CF pharmacological treatment, VX-809 (commercial name Lumacaftor) is the most used drug for patients carrying F508del-CFTR mutation. This drug corrects the aberrant folding of F508del-CFTR by favoring the correct intramolecular interactions, thus enabling a higher number of copies of the defective protein to reach the plasma membrane. Localization of Organelle Proteins by Isotope Tagging after Differential ultra-Centrifugation (LOPIT-DC, https://doi.org/10.1038/s41467-018-08191-w) workflow was used to study the spatial localization of proteins in the CFBE41o- cells and how it is impacted by CFTR rescue triggered by VX-809. LOPIT-DC is a powerful and well-established tool for the investigation of the spatial distribution of global proteome within cells, which combines subcellular fractionation based on differential centrifugation, quantitative mass spectrometry, and machine learning. Its application provides a global snapshot of the steady-state subcelluler distribution of proteins. The aim of this project is to identify proteins that change their cellular localization in association with the treatment, to uncover molecules that play a role in the trafficking of the defective CFTR to the plasma membrane.

INSTRUMENT(S): Orbitrap Eclipse

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Cystic Fibrosis

SUBMITTER: Clarissa Braccia  

LAB HEAD: Kathryn S. Lilley

PROVIDER: PXD028393 | Pride | 2022-08-11

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Clarissa_C_Rep1_F.msf Msf
Clarissa_C_Rep1_F1.raw Raw
Clarissa_C_Rep1_F2.raw Raw
Clarissa_C_Rep1_F3.raw Raw
Clarissa_C_Rep1_F4.raw Raw
Items per page:
1 - 5 of 33
altmetric image

Publications


<h4>Background</h4>Cystic Fibrosis (CF) is a genetic disorder affecting around 1 in every 3000 newborns. In the most common mutation, F508del, the defective anion channel, CFTR, is prevented from reaching the plasma membrane (PM) by the quality check control of the cell. Little is known about how CFTR pharmacological rescue impacts the cell proteome.<h4>Methods</h4>We used high-resolution mass spectrometry, differential ultracentrifugation, machine learning and bioinformatics to investigate both  ...[more]

Similar Datasets

2022-08-11 | PXD028355 | Pride
2016-07-01 | E-GEOD-70442 | biostudies-arrayexpress
2016-07-01 | GSE70442 | GEO
2013-04-10 | GSE40445 | GEO
2023-03-02 | GSE203007 | GEO
2023-04-01 | GSE226758 | GEO
2022-05-04 | PXD032836 | Pride
2013-04-10 | E-GEOD-40445 | biostudies-arrayexpress
2023-11-14 | PXD041950 | Pride
2012-06-17 | E-GEOD-33319 | biostudies-arrayexpress